Debra Crawford, DO
Hospice and Palliative Medicine · Lawton, OKNPI 1114139334
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 25.8% of the total.
Across 23 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$125
- Pfizer$120
- Sumitomo Pharma America, Inc.$44
- Innovation Technologies Inc$40
- Agile Therapeutics, Inc.$29
- Hologic Sales And Service, LLC$28
- plus $99 from 5 others
What the payments were for
- Food & beverage$46596%
- Education$194%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $125 |
| Pfizer | 6 | $120 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Innovation Technologies Inc | 1 | $40 |
| Agile Therapeutics, Inc. | 1 | $29 |
| Hologic Sales And Service, LLC | 2 | $28 |
| Exact Sciences | 2 | $28 |
| Therapeuticsmd, Inc. | 1 | $21 |
| Medtronic | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
How this compares
Too few hospice and palliative medicine providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CombipatchEstradiol/Norethindrone Acet | 13 | $5,105 |
| Estradiol | 81 | $3,935 |
| Fluconazole | 21 | $156 |
| Potassium Chloride | 14 | $148 |
| Acyclovir | 18 | $132 |
| Atorvastatin Calcium | 12 | $81 |
| Metronidazole | 16 | $80 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Lawton
- Shelley ShounTulsa$4K
- Meenakshi SinghOklahoma City$675
- Samuel CookOklahoma City$508
- Nancy WilliamsTulsa$412
- Borna MansouriOklahoma City$316
- Steven DrabekOklahoma City$220
- James RossTulsa$196
- Niket MuniOklahoma City$134
- Shahnawaz IjazTulsa$124
- Blayne BordwineOklahoma City$108
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.